George Vincent Named as Kroger Secretary and General Counsel
NEXGEL (NASDAQ: NXGL), a provider of medical and OTC hydrogel products, announced its CEO Adam Levy will participate in the 6th Annual CEO Networking Event hosted by Semco Capital. The event will take place on June 2, 2025 in Chicago, featuring a fireside chat with Scott Weis.
The networking event brings together microcap companies with strong management teams and growth potential. Interested investors can contact Scott Weis for attendance information.
NEXGEL (NASDAQ: NXGL), fornitore di prodotti medicali e OTC a base di idrogel, ha annunciato che il suo CEO Adam Levy parteciperà al 6° Evento Annuale di Networking per CEO organizzato da Semco Capital. L'evento si terrà il 2 giugno 2025 a Chicago e includerà una conversazione informale con Scott Weis.
L'evento di networking riunisce società microcap con team di gestione solidi e potenziale di crescita. Gli investitori interessati possono contattare Scott Weis per informazioni sulla partecipazione.
NEXGEL (NASDAQ: NXGL), proveedor de productos médicos y OTC de hidrogel, anunció que su CEO Adam Levy participará en el 6º Evento Anual de Networking para CEO organizado por Semco Capital. El evento se llevará a cabo el 2 de junio de 2025 en Chicago, e incluirá una charla informal con Scott Weis.
El evento de networking reúne a empresas microcap con equipos directivos sólidos y potencial de crecimiento. Los inversores interesados pueden contactar a Scott Weis para obtener información sobre la asistencia.
NEXGEL (NASDAQ: NXGL)는 의료 및 일반의약품(OTC) 하이드로겔 제품 공급업체로, CEO 아담 레비가 Semco Capital이 주최하는 제6회 연례 CEO 네트워킹 행사에 참여할 예정이라고 발표했습니다. 이 행사는 2025년 6월 2일 시카고에서 열리며, 스콧 와이스와의 대화 시간이 포함됩니다.
이 네트워킹 행사는 강력한 경영진과 성장 잠재력을 가진 마이크로캡 기업들을 한자리에 모읍니다. 참석을 원하는 투자자는 스콧 와이스에게 문의할 수 있습니다.
NEXGEL (NASDAQ : NXGL), fournisseur de produits médicaux et OTC à base d'hydrogel, a annoncé que son PDG Adam Levy participera au 6e événement annuel de réseautage pour PDG organisé par Semco Capital. L'événement aura lieu le 2 juin 2025 à Chicago et comprendra une discussion informelle avec Scott Weis.
L'événement de réseautage réunit des entreprises microcap disposant d'équipes de direction solides et d'un potentiel de croissance. Les investisseurs intéressés peuvent contacter Scott Weis pour obtenir des informations sur la participation.
NEXGEL (NASDAQ: NXGL), ein Anbieter von medizinischen und OTC-Hydrogel-Produkten, gab bekannt, dass sein CEO Adam Levy am 6. jährlichen CEO-Networking-Event teilnimmt, der von Semco Capital veranstaltet wird. Die Veranstaltung findet am 2. Juni 2025 in Chicago statt und beinhaltet ein Gespräch mit Scott Weis.
Das Networking-Event bringt Microcap-Unternehmen mit starken Management-Teams und Wachstumspotenzial zusammen. Interessierte Investoren können Scott Weis für Teilnahmeinformationen kontaktieren.
- None.
- None.
LANGHORNE, Pa., May 21, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will participate in the 6th Annual CEO Networking Event hosted by Semco Capital in Chicago on Monday, June 2, 2025 from 1-9 p.m. CT. During the event Mr. Levy will participate in a fireside chat hosted by Scott Weis of Semco Capital.
The Annual CEO Networking Event hosted by Semco Capital brings together a consortium of leading microcap companies with unique business models, strong management teams, and considerable opportunity for enhanced growth and value. Investors interested in attending may contact Scott Weis at scott@semcocapital.com for more information.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com
FAQ
When is NEXGEL (NXGL) CEO presenting at the Semco Capital event?
How can investors attend NEXGEL's (NXGL) presentation at the Semco Capital event?
What type of companies participate in the Semco Capital CEO Networking Event?
What products does NEXGEL (NXGL) specialize in?
